Section divider

Battling HIV and HPV since 2003.

  • More than 44,000 men and boys have received voluntary medical male circumcision services, thereby benefiting from this procedure’s protective effect against HIV infection.
  • Over 54,000 people have received HIV testing and counseling services, and those who tested positive were linked to treatment and care.
  • With Jhpiego support, in 2015 the Ministry of Health launched a “See and Treat” strategy to combat cervical cancer. Since then, access to cervical cancer screening and prevention services has increased, with 51 sites around the country providing visual inspection with acetic acid (VIA) to immediately identify women at high risk of developing cervical cancer.
  • More than 32,000 women have been screened through VIA and 85% of those with pre-cancerous lesions were treated with cryotherapy or the loop electrosurgical excision procedure to prevent the development of cervical cancer.

Our Technical Areas in Botswana

Our Work in Botswana

With funding from the U.S. Department of Defense, Jhpiego is working with the Botswana Defence Force to strengthen the availability and quality of HIV prevention, care and treatment services for service members and communities around military sites. The services being supported include HIV testing and counseling, condom distribution, provision of voluntary medical male circumcision, HIV care and treatment, HIV clinical laboratory services and the HIV monitoring system. Jhpiego is: 1) helping to raise the profile of HIV prevention through high-level, coordinated multi-site campaigns; 2) increasing the availability of prevention commodities such as condoms for service members; 3) increasing the focus on circumcision as a prevention strategy by training military health care providers (thereby increasing the availability of circumcision services at military sites and raising awareness of the importance of circumcision among military personnel); 4) improving access to HIV care and treatment, focusing on access to viral load testing and strengthening viral load cascade; 5) strengthening laboratory quality management systems and accreditation; and 6) strengthening the HIV monitoring system. The project targets 13 Botswana Defence Force garrisons and camps throughout the country and the adjacent civilian communities.

With funding from Roche Products Ltd., Jhpiego is adopting a systematic strategy based on evidence-based interventions to support the Government of Botswana to improve access to high-quality breast health care for women. The cornerstones of this strategy include a strong learning and advocacy agenda, awareness building about breast health among providers and communities in both urban and rural areas, and demonstration of a well-functioning early detection system at the primary health care level that is linked to timely diagnosis and treatment at referral hospitals. Jhpiego will support the establishment of a scalable service delivery model with early detection using clinical breast examination at the primary health care level and setting up efficient referral pathways for women diagnosed with cancer to diagnostics and treatment at the referral facilities.

Jhpiego is a partner under ABLE, a five-year project funded by the U.S. Centers for Disease Control and Prevention and led by the Botswana–University of Maryland School of Medicine Health Initiative. Under this project, Jhpiego leads the implementation of pre-exposure prophylaxis (PrEP) and HIV self-testing services. In the area of PrEP, Jhpiego is building the capacity of the Ministry of Health and Wellness to scale up PrEP for key populations, providing technical assistance to ensure PrEP services are provided according to national guidelines, and improving PrEP access. In addition, Jhpiego is supporting the scale-up of HIV self-testing.